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Abstract: A ZnO containing nano-hydroxyapatite/chito-
san (n-HA/CS) cement was developed and its bone forma-
tion ability was investigated in vitro and in vivo. The phys-
ico-chemical properties of the cement were determined in
terms of pH variation during and after setting, injectability
and wettability. The results indicated that, the pH varied
from 7.04 to 7.12 throughout the soaking of the cement in
distilled water. The injectability was excellent during the
ﬁrst 4 min, but the cement became less injectable or even
not injectable at all after 7 min setting. The static contact
angle of the cement against water was 53.5 6 2.78. The
results of immersion tests in simulated body ﬂuid (SBF)
indicated that the cement exhibited excellent bone-like ap-
atite forming ability. In vivo studies, involving the installa-
tion of the cement of tibial-bone defects in rabbit tibia
revealed an inﬂammatory response around the cement at 3
days of implantation. After 4 weeks, the inﬂammation
began to disappear and the cement had bound to the sur-
rounding host bone. Radiological examination also con-
ﬁrmed that the ZnO containing n-HA/CS cement signiﬁ-
cantly induced new bone formation. These results suggest
that the ZnO containing n-HA/CS cement may be beneﬁ-
cial to enhance bone regeneration in osseous defect sites.
 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A:
269–279, 2010
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INTRODUCTION
Hydroxyapatite (HA) with chemical and crystallo-
graphic similarity to the apatite in human bone and
teeth can form a direct chemical bond with sur-
rounding bone tissue and therefore has been used
extensively in orthopedics and bone regeneration.1–3
However, a major disadvantage of sintered HA
blocks is that it exists in a bulk form, requiring sur-
geons to ﬁt the surgical site around the implant or to
carve the graft to the desired shape,4 while HA in
the form of particles has a tendency to migrate from
the implantation site.5 Due to these reasons, the ther-
apeutic effects of HA tend to be deteriorated in
clinic. Therefore, developing a new kind of material
with moldability and in situ self-hardening ability
and, at the same time maintenance of the material in
the defect site is desirable and necessary for orthope-
dic repair.
Currently, natural polymers have been paid a
great deal of attention by many researchers owing to
some of their unique properties, such as nontoxicity,
degradability, and good biological compatibility.6–9
Chitosan (CS) is an N-deacetylated form of chitin
and has various degrees of substitution for N-acetyl
groups. It has been proven that CS can degrade
in vivo into nonharmful and nontoxic products10–12
and thus has been used in many biomedical applica-
tions, including wound dressings and drug or gene
delivery.13 In addition, a large amount of amino
groups present in the chains give CS high positive
charges, through which CS can bind tightly with
negatively charged cells via electrostatic interac-
tion.14,15 When applied to bone defects in animal
models, CS was found to improve osteogenesis and
angiogenic activity.16,17 However, the poorer me-
chanical strength of CS makes it impossible to bear
the load that bone is usually subjected to and thus,
it tends to collapse.
Accordingly, inorganic–organic composites for
bone repair should be developed and are expected
to enhance the mechanical properties of the polymer
matrix with particle reinforcement and to reduce the
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disadvantages associated with the individual compo-
nent as well as to improve the overall biological
response to the implant.18–21 Nano-hydroxyapatite/
Chitosan (n-HA/CS) composites have been studied
extensively and proved to combine the advantages
of the two included components.19,22–24 However in
a previous study, the incorporation of zinc oxide
(ZnO) has been proven to shorten the setting time
and enhance the mechanical strength and to improve
the bioactivity and antibacterial activity of n-HA/CS
composite.25
As a consequence, in the current study the in vitro
bioactivity and in vivo biological response of ZnO
containing n-HA/CS composite was investigated
further.
MATERIALS AND METHODS
Chitosan was obtained from Haidebei Co. (Jinan,
China). The degree of deacetylation was 80% and the
weight-averaged molecular weight was about 250,000. All
other chemicals are of analytic grade and used as received.
The n-HA/CS composite powder was synthesized by the
coprecipitation method described detailed in the Ref. 27.
Composition of n-HA/CS composite cement
The fast-setting cement was mainly composed of a pow-
der phase containing n-HA/CS (70 wt % n-HA) composite
and a liquid phase comprised of 2 wt % citrate acid, 1 wt
% NaH2PO4, and 1 wt % CaCl2 aqueous solution. The
powder phase also contained 8 wt % ZnO used as a set-
ting accelerator and the precise concentrations of n-HA,
CS, and ZnO in the ﬁnal powder mixture were 64.4, 27.6,
and 8 wt %, respectively. According to the previous
research,25 the liquid/powder (L/P) ratio of 1.0 mL/g was
selected to be used in this study. The cement paste was
prepared by mixing the powder with liquid for 20 sec by
hand. The paste was then used to prepare samples for
evaluating their properties.
pH variation during and after setting
Two grams of cement powder was mixed with 2 mL liq-
uid at room temperature for about 20 sec and the paste
was quickly transferred into a plastic mold with a closed
bottom. The mold was then immersed for 60 h in 50 mL of
distilled water at 378C under gentle stirring at 200 rpm.
The pH of the distilled water was measured which a com-
pact type pH meter at 5-h intervals. The obtained pH data
were the average values of three measurements.
Injectability
Injectability is described as the weight loss percentage
(I%) between the cement paste extruded from the syringe
to the cement paste remaining inside the syringe. To mea-
sure the injectability of the cement, a method was used as
proposed by other authors.26,40 Three grams of cement
were transferred to a 5-mL disposable syringe with a noz-
zle diameter of 2.0 mm and then extruded through the
nozzle at a crosshead speed of 15 mm/min, using a peak
load of 100 N in a Universal Testing Machine. Measure-
ments were repeated three times for reproducibility.
Finally, the injectability was determined as follows:
1% ¼ 1 ððthe mass of cement remaining in the syringe=
the starting cement massÞ 3 100%Þ ð1Þ
Wettability
The static contact angle of n-HA/CS cement was meas-
ured using a contact angle goniometer (Model JY-82;
Chengde Experimental Machine Plant, China). Distilled
water was dropped onto the surface of the cement pellet
before measuring. The data presented were the mean
value of at least six independent measurements.
In vitro behavior
Simulated body ﬂuid (SBF) was used for in vitro bioactiv-
ity experiments. SBF, proposed by Kokubo and coworkers,27
was prepared by dissolving reagent-grade chemicals
of NaCl, NaHCO3, KCl, K2HPO43H2O, MgCl26H2O,
CaCl22H2O, Na2SO4, and tris(hydroxymethyl)-aminometh-
ane into distilled and deionized water and buffered to pH
7.4 at 378C with hydrochloric acid and has ion concentra-
tions that are nearly the same as those of human blood
plasma.
Cement specimens with dimensions of F 10 3 1 mm
were immersed in plastic tubes containing 15 mL of SBF.
The tubes were sealed to minimize the change in pH and
incubated in a water bath at 378C under gentle reciprocal
motion. The samples were incubated in SBF for 1, 2, 4, 6,
and 8 weeks, respectively, and the SBF was changed every
7 days. After the different periods of immersion time,
specimens were removed out from SBF, rinsed with dis-
tilled water and dried prior to analysis.
The samples were gold coated under an argon atmos-
phere using a sputter coater and were examined using a
JEOL JSM5600LV scanning electron microscope (SEM). The
aggregations deposited on the surface of the samples were
analyzed by an energy dispersive X-ray analyzer (EDX,
PV9100-65), which was directly connected to the SEM. The
concentrations of Ca and P ions in SBF after immersion
were determined by an inductively coupled plasma atomic
emission spectrometer (ICPS-7500). All reported data were
the average value of ﬁve tests.
In vivo evaluation
To investigate the in vivo bone forming ability of the
ZnO containing n-HA/CS cement, preharedened cement
samples were implanted into the tibial bone of rabbits. In
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this study, 24 New Zealand white rabbits (2.0–3.0 kg) were
assigned randomly to one of four groups designating as 3-
day, 4-, 8-, and 12-week groups. Each group consisted of
six rabbits. The hind limbs of the rabbits were shaved and
disinfected after induction of general anesthesia with a
mixture of 10% ketamin hydrochloride and xylazinehydro-
chloride (3 mL/kg). Subsequently, a vertical incision was
made to disclose the skin and periosteum and the tibia
was exposed. A hole with a diameter of 5 mm and depth
of 8 mm was drilled in the proximal epiphysis of the tibia.
After rinsing in order to remove bone fragments, in 20 rab-
bits the tibial defects were ﬁlled with prehardened sam-
ples, while the defects in the other four rabbits were left
empty and used as controls. Finally, the wounds were
sutured with silk threads and then disinfected. After the
animals were recovered from anesthesia, they were
allowed free movement in their cages.
The rabbits were sacriﬁced at 3 days, 4, 8, and 12 weeks
post operation. X-ray radiographs of the rabbit tibias with
the implanted materials were taken using a Philips 1025 X-
ray Radiograph System (Japan). The femurs with implants
were dissected free of soft tissues and ﬁxed with 10% neu-
tral buffered formalin for 24 h. Fixed specimens were
decalciﬁed in general acidic decalcifying solution for 72 h,
embedded in parafﬁn wax, cut into 7-lm sections and
stained with Masson trichrome (M-T) as well as hematoxy-
lin and eosin (HE) for light microscopic examination.
RESULTS
pH variation during and after setting
Figure 1 shows the pH variation of the distilled
water during soaking of the cement paste. The
measured pH was 7.04 just after immersion and
subsequently increased gradually to 7.12 after 45 h.
Thereafter, the pH of the distilled water remained
almost constant.
Injectability assay
The variation of injectability against time is plotted
in Figure 2. It is obvious that the injectability of the
cement was higher during the ﬁrst 4 min of setting
and, after this time, the cement shows to be less
injectable. Injectability decreased drastically after 7-
min setting due to the high viscosity of the paste
and at 9 min, the cement was practically no longer
injectable.
Wettability
The static contact angle reﬂects directly the wett-
ability of a material. In general, the smaller the con-
tact angle of a material against water, the better the
wettability of the material is, that is to say, the mate-
rial is more hydrophilic. In this experiment, the
static contact angle of the cement against water is
53.5 6 2.78, which is relatively small, meaning that
the cement has good hydrophilicity.
In vitro behavior
Figure 3 shows the SEM photos of the cement af-
ter being immersed in SBF for different periods of
time, in which the over-right insets are the photos
with high magniﬁcation. It can be seen from Figure
3 that the nucleation of Ca–P granulates has taken
place during the ﬁrst week of immersion and many
Ca–P spherical particles deposited on the cement
surface, as has been reported elsewhere.58–62 After
2 weeks, the number and size of the Ca–P particles
deposited on the cement surface increased and
there were large number of islands of Ca–P whose
diameters enlarged continuously, as shown in Figure
3(b–d).
Figure 1. pH variation with the soaking time of the
cement in distilled water.
Figure 2. The variations of injectability of the cement
against the setting time.
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At 8 weeks of immersion, the growth and coales-
cence of Ca–P particles continued and then formed a
Ca–P layer covering on the specimen surface, as dis-
played in Figure 3(e). These Ca–P particles or layers
are apatite according to EDX analysis, same as those
reported elsewhere.58–62
The concentrations of Ca ion and P groups in SBF
as a function of the immersion time were plotted in
Figure 4. It was demonstrated that the concentration
of Ca ion dropped from 83.23 to 74.89 ppm dramati-
cally during the ﬁrst week of immersion, then
rebounded till 2 weeks. After that, the concentration
of Ca ion descended continually, as shown in Figure
4(a). It could be found from Figure 4(b) that the con-
centration of P groups in SBF declined all through
the immersion. But it is noticeable that the concen-
tration of P groups decreased rapidly at the ﬁrst
week and since then, decreased steadily. According
to the above mentioned, it could be concluded that,
the initially fast decreases in the Ca and P ion con-
centrations might have been due to the adsorption
of these ions to the chitosan surface and the rapid
deposition of Ca and P ions on the cement. Then,
the fact that Ca concentration rebounded till the sec-
ond week might be induced by the continuous disso-
lution of the n-HA in the cement as well as the con-
tribution of the small amount of P groups from
cement liquid. After that, the gradual decrease of the
Ca concentration suggested that the microenviron-
ment with high Ca and P concentrations around the
cement accelerated the agglomeration of Ca–P de-
posit, and thus dropped the Ca concentration in the
solution continuously. In comparison, the P concen-
tration remained the descending trend throughout
the immersion. However, the changing trend of the
P concentration indicating the quick accumulation of
Ca–P deposits at the ﬁrst week, and also proved that
the deposition process proceeded all through the
immersion period.
Figure 3. SEM photos of the cement immersed in SBF for different periods of time: (a) before immersion; (b) 1 week;
(c) 2 weeks; (d) 4 weeks; (e) 6 weeks, and (f) 8 weeks.
Figure 4. The content of Ca (a) and P (b) in SBF solution
as a function of the immersing time.
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In vivo evaluation
Macroscopic inspection and
radiological examination
It was found that these rabbits began to move
about 3 days postoperatively and appeared no post-
operative complications. The implants connected
with the surrounding bone tissues tightly at 4 weeks
implantation and were hard to be taken out. After
8 weeks, the implants combined with the around tis-
sues more tightly and these wounds healed gradu-
ally. Although 12 weeks after implantation, a large
amount of new bone formed surrounding these
implants and the tubercle at the tibia grew thicker,
in which these implants were encapsulated entirely.
The sequential radiological changes in the healing
areas are shown in Figure 5. On the third day, bone
density around the implant decreased markedly,
behaving a distinct radiolucent area, which indicated
a larger gap between the implant and the around tis-
sues [Fig. 5(a)]. After 4 weeks, there was still a radio-
lucent region around the implant, but it became
blurred, implying that the margin of the cement
began to be adsorbed and replaced by a little
amount of newly formed bone [Fig. 5(b)]. The radio-
lucent area became gradually indistinct and a dis-
crete bone neoformation became more clearly
deﬁned with a bone wall and a clear osteosclerotic
reaction, suggesting that adsorption of the cement
was still continued and, the cement integrated with
the surrounding bone gradually, as shown in Figure
5(c). Bone formation continued and at week 12, the
implant density was very similar to the surrounding
bone, implying that the newly formed bone ﬁlled
completely the interfacial crevices between the
cement and the host bone as well as the adsorbed
sites for the cement.
Histological observation
At 3 days after implantation, a local accumulation
of polymorphonuclear leucocytes and bone trabecu-
lae fractures with hemorrhagic areas were observed
as normal consequences of surgical trauma, as
shown in Figure 6. In contrast, the control defect
was ﬁlled with a coagulum (not shown here).
At 4 weeks of implantation, light microscopic
image of decalciﬁed section with HE staining
showed that a thin layer of connective tissue sur-
rounded the implant and newly formed woven bone
loosely arranged at the outer of the layer, mean-
while, chitosan degradation took place and some
crevices appeared on the surface of the implant, and
these sites were inﬁltrated with ﬁbrous tissue [Fig.
7(a)]. M-T staining also indicated that loosely collag-
enous tissue, which was stained blue, was deposited
surrounding the implant, suggesting the formation
of new bone, as shown in Figure 7(b). In the control
defect without cement implantation at 4 weeks [Fig.
7(c)], connective tissue spanned the host bone mar-
gin and the defect was completely ﬁlled with ﬁbrous
connective tissue. However, negligible amount of
new bone was observed.
After 8 weeks of surgery, the connective tissue
layer almost disappeared and extensive new bone
formation was seen in the gap between the host pa-
rietal bone and the cement, implying that bone inte-
gration was the main biological activity in this pe-
riod [Fig. 8(a)]. Apart from this, bone growth took
place centripetally toward the degraded sites and
the crevices in the implant. Part of the newly formed
woven bone showed lamellar-like structures and
became more mature, which could be clearly
observed in Figure 8(b). At this period, although
new bone was rapidly formed, complete reunion of
new bone had not occurred. In the control, the scar
Figure 5. Radiographs of the cement after implantation: (a) 3 days; (b) 4 weeks; (c) 8 weeks, and (d) 12 weeks.
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tissue was mainly ﬁbroblasts that had multiplied
upon the defect with newly formed capillaries, as
shown in Figure 8(c).
At 12 weeks after implantation, new bone progres-
sively formed around the implant. Mineral trabecu-
lae dispersed randomly around the implant, began
to link together and at the same time, densely
mature lamellar bone could also be observed. In
addition, a lot of blood vessels were found to inﬁl-
trate into the newly formed trabeculae [Fig. 9(a)].
Collagen deposition increased signiﬁcantly at 12-
week postoperation and in Figure 9(b), chitosan was
stained dark red, whereas collagen deposition
appeared as dense blue staining, demonstrating that
new bone remodeling had occurred at this stage. In
comparison, microscopic examination on the control
after 12 weeks of implantation [Fig. 9(c)] showed
that the defect was still ﬁlled with ﬁbrous scar tis-
sue, which was similar to that observed in the con-
trol at 8-week post operation, no newly-formed bone
could be seen at the center of the defect.
DISCUSSION
A cement for use in clinical practice must have
good handling, appropriate setting time, as well as
suitable pH and wettability.28 It has been reported
that pH during the hardening process will inﬂuence
tissue reaction to the cement.29 Acidic conditions
tend to induce aseptic inﬂammatory response of sur-
rounding tissue.30 In addition, pH may also inﬂu-
ence the surface chemistry, thereby affects the bio-
logical response, such as proliferation and spreading
of cells.31 Chou et al.32 have described the effect of
different initial pH of SBF causing morphological
Figure 7. Light micrographs of tissue responses around the cement implants and the control for 4 weeks: (a) HE staining
(3200); (b) Masson staining (3200), and (c) HE staining of the control (3200). C, cement. [Color ﬁgure can be viewed in
the online issue, which is available at www.interscience.wiley.com.]
Figure 6. Light micrographs of tissue responses around
the cement implant for 3 days. HE staining (3200); C,
cement. [Color ﬁgure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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Figure 8. Light micrographs of tissue responses around the cement implants and the control for 8 weeks: (a) HE staining
(3200); (b) Masson staining (3200), and (c) HE staining of the control (3200). C, cement. [Color ﬁgure can be viewed in
the online issue, which is available at www.interscience.wiley.com.]
Figure 9. Light micrographs of tissue responses around the cement implants and the control for 12 weeks: (a) HE stain-
ing (3200); (b) Masson staining (3200), and (c) HE staining of the control (3200). C, cement. [Color ﬁgure can be viewed
in the online issue, which is available at www.interscience.wiley.com.]
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difference in the accelerated biomimetic apatite, and
reported that higher initial pH promotes faster pre-
cipitation of precursor spheres which are comprised
of fewer stable, and more unstable phases which
will subsequently undergo rapid phase transforma-
tion into large platelike structures, while micro- and
nano-topography has also been shown to alter cellu-
lar morphology, cytoskeleton and proliferation. In
this study, pH value of the cement during and after
setting varies from 7.04 to 7.12 during the immersion
of 0  45 h, after that the pH remains about 7.12,
which is very close to the pH of human body ﬂuid
(about 7.25). The slightly basic environment would
be expected to alleviate the inﬂammatory response,
and also accelerate the deposition of bone-like apa-
tite33 and the differentiation, spreading, and prolifer-
ation of osteoblasts, and thus facilitate defect repair.
The applicability of injectable self-setting biomate-
rials is largely dependent on its self-setting character-
istics, such as injectability and setting times. Often,
injectability properties of cements are characterized
by extrusion tests. According to the results reported
by other authors34,35 the more cement could be
extruded, the more injectable the cement was. Gener-
ally, cements intended for ﬁlling irregular bone
defects must be ﬂuid, also they should have enough
consistency to prevent early leakage of the cement.
Furthermore, the time of injection should last enough
to permit the injection without additional problems.
However, many reports have shown that improving
the injectability of the cement paste can inadvertently
prolong the cement setting time.36–38 For example,
the use of trisodium citrate solution instead of water
improved the injectability of a CPC greatly, but
signiﬁcantly increased its setting time.26 A long set-
ting time could cause problems because of the
cement’s inability to support stresses within this
time period. For instance, a severe inﬂammatory
response occurred when the CPC failed to set and
disintegrated, likely due to a low initial mechanical
strength.36,38 In the present study, it can be seen from
Figure 2 that there has a sharp decrease for the inject-
ability after setting for 7 min, meaning that before
7 min the cement is relatively workable, after that it
is hard to handle. The injection time is regarded as a
consequence of the viscosity increase and viscoelastic
behavior of the cement during setting.39,40 Some
authors have deﬁned a ‘‘dough-time D’’ as the time
when injectability decreases drastically as a function
of the injection time.41 Hereby, it can be concluded
that the setting time of 7 min should be referred
as the dough-time D for the so obtained cement in the
paper.
Wettability is perhaps one of the most important
factors determining the quantity and quality of
adsorbed proteins and the biocompatibility, and that
the static contact angle reﬂects directly the wettabil-
ity of a material.42,43 The static contact angle has
been proven to be the most signiﬁcant determinant
of adhesion strength and, in turn, the cell growth
rate depends on the adhesion strength.44 Osteoblasts
preferentially adhere onto surfaces of biomaterials
with the similar wettability to themselves. The aver-
age contact angle of a water droplet on an osteoblast
monolayer was reported to be 26.9 6 0.38, and the
contact angles of bone biomaterial like sandblasted
titanium and hydroxyapatite to be 41 or 438, respec-
tively.43 Whereas, the contact angle of the cement
against water in this study is 53.5 6 2.78. So, it can
be postulated that osteoblasts will preferentially
adhere onto the surface with similar wettability.
Therefore, the cement is favorable to the protein
adsorption and osteoblast adhesion, while cell adhe-
sion is regarded as a crucial phase in many biologi-
cal processes and primarily in tissue repair.
Generally, artiﬁcial materials implanted into bone
defects are encapsulated by ﬁbrous tissue isolated
from the surrounding bones. It has been reported,
however, during the recent years that some bioactive
ceramics, for example, Bioglass, sintered hydroxyap-
atite, and glass-ceramic A-W, bond to living bone
without forming ﬁbrous tissue around them, which
when implanted into bone defects, forms spontane-
ously a layer of biologically active bonelike apatite
on their surfaces to induce chemical integration of
bone tissue.1,2,45,46 It is a common notion that bone-
like HA plays an essential role in the formation,
growth, and maintenance of the bone tissue–bioma-
terial interface, and this bone-like apatite layer can
be reproduced in vitro at physiological temperatures
in simulated body ﬂuid (SBF),47–49 a solution with
ion concentrations and a pH value similar to those
of human blood plasma. In this study, the SEM ob-
servation (Fig. 3) indicated that apatite started to
precipitate after 1 week of immersion in SBF and the
spherulites increased in both number and size with
immersion time, which is similar to that reported by
others,50 suggesting the cement exhibits high bioac-
tivity. In addition, the results of the Ca and P con-
centration variations (Fig. 4) provided further
evidence that bone-like apatite formed on the cement
in the ﬁrst week of soaking. In the recent years,
microcrystalline HA powders have been employed
as seeds for the apatite evolution in CPCs due to
HA seeds providing sites for heterogeneous nuclea-
tion.51 Yang et al.52 have also reported that addition
of apatite seeds into the starting CPC powder mix-
ture does promote the formation of deposited apatite
as they themselves provide nucleation sites for HAp
crystal growth. For this reason, it can be inferred
that the n-HA granules in the present cement pow-
der may serve as nucleation sites for apatite precipi-
tation. During the immersion, the dissolution of
n-HA and the contribution of additional small
276 LI ET AL.
Journal of Biomedical Materials Research Part A
amount of PO4
32 and Ca2þ lead to the precipitation
of apatite, once the main ionic species, such as Ca2þ
and PO4
32, supersaturate the solution. Furthermore,
data in the literature show that the rate of apatite
formation can be increased by the presence of phos-
phate in the solution.53,54 Also, it has been reported
that the high surface charge density of chitosan can
attract the adsorption of Ca and P ions on its sur-
face.55,56 Although Wan et al.57 have reported that
the hydroxyl groups of the acetyl glucosamine resi-
dues on chitin are able to bind both Ca and P ions
in a loose fashion, increasing the degree of supersa-
turation in the vicinity of the substrate. When the
local degree of supersaturation is high enough, the
critical radius for nucleation is achieved and Ca–P
nuclei are formed. Once the apatite nuclei are
formed, they can spontaneously grow by consuming
the Ca and P ions in the SBF, as the SBF is already
supersaturated with respect to the apatite even
under normal conditions.58 Further growth of crys-
tals takes place when supernatant ions ﬁll the lattice
sites predetermined by the initially formed nuclei.
This outward growth from a point leads to the
observed spherical morphology of the deposits,
which was also reported elsewhere. Similar nuclea-
tion of Ca–P deposits was also observed for the ZnO
containing n-HA/CS cement incubated in SBF in this
study. We could observe that the deposition of Ca
and P ions occurred during the ﬁrst week of immer-
sion, and the spherical Ca–P deposits increased and
agglomerated with soaking time. With the immer-
sion time and the incorporation of other ions, these
Ca–P deposits underwent a series of compositional
adjustments and phase structural variations, and
ultimately changed into bone-like apatite layer. In
addition, the high apatite-forming ability of the pres-
ent cement might be relevant to the incorporation of
ZnO in the cement powder. It is well known that
zinc (Zn), titanium (Ti), tantalum (Ta), and zirco-
nium (Zr) are all belonging to the family of transi-
tional metals, and extensive studies have indicated
that Ti, Ta, and Zr enable the formation of bone-like
apatite on their surfaces in SBF through the catalytic
effect of the TiOH,59 TaOH60,61 and ZrOH62
groups, respectively. Therefore, it can be postulated
that, when ZnO encounters with aqueous solution,
plenty of ZnOH groups will be formed and act as
the apatite nuclei, and thus trigger the formation of
bone-like apatite on the surface of n-HA/CS cement
in SBF.
Our original motive of introducing ZnO into the
cement was to shorten the setting time and reinforce
the cement, and the obtained results were also desir-
able, which has been reported previously.25 How-
ever, the effects of ZnO on the biological role of the
cement in the present study have also become an im-
portant topic in the research ﬁeld of bone formation
recently. Zn is an essential trace element having
stimulatory effects on bone formation in vitro and
in vivo.63,64 Zn2þ was also found to increase bone
protein, calcium content, and alkaline phosphatase
activity in rat calvaria in vitro.65 Ito et al.66–69 pre-
pared Zn containing apatite ceramics and found that
Zn2þ release enhanced osteoblastic cell proliferation
and differentiation in vitro and also promoted bone
formation in vivo. In the study, ZnO in the cement
powder can react with water or acid and release a
lot of Zn2þ, which may help facilitate more rapid
new bone formation and thus accelerate bone defect
repair. It could be seen from Figure 5 that bone neo-
formation around the implant was prominent, and at
12 weeks after surgery the gap between the implant
and host bone was almost completely ﬁlled with
new bone. The process of bone neoformation is
more evident if observed from the light micro-
graphs, as shown in Figures 6–9. These results are
similar to those reported by Ooms70 for implants in
the cortical bone in goats and Wang71 for implants
in the radii and tibia of rabbits. However, inﬂamma-
tory and foreign body responses were observed
around the cement at 3 days of implantation. Miya-
moto et al. reported severe inﬂammation around cal-
cium phosphate cement implanted immediately after
mixing.72 They proposed that the severe inﬂamma-
tory was the result of a decrease of transformation
to HA and the crumbling of the cement. In this
study, the inﬂammatory may be caused by the
crumbling of the cement or/and the excessive ZnO
introduced into the cement powder. But it is obvious
that the inﬂammation response was alleviated to a
great extent with the implantation time, and till 4
weeks was almost not observed. In the study,
although we found the degradation and new bone
replacing of the ZnO containing n-HA/CS cements,
the duration of the experiment was relatively too
short to investigate the resorption of the cement in
details. Thus, further experiments are necessary to
investigate it.
CONCLUSIONS
In conclusion, our newly developed ZnO contain-
ing n-HA/CS cement showed excellent osteoconduc-
tivity over a 12 weeks implantation period. How-
ever, it will be necessary to carry out further experi-
mental research to validate the clinical use this
material in future.
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